Patents by Inventor David McCarthy

David McCarthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250262940
    Abstract: The present invention is a diagnostic testing module for controlling an electronic control unit of an automobile engine. The module has a processor, a housing for the processor, an adaptor cable for connecting the processor to the electronic control unit, a user interface screen for controlling the processor of the module and presenting data to the user and an antenna to transmit data. The module is characterized in that the module has a mount for attaching the housing to the automobile so that the module can travel with the automobile.
    Type: Application
    Filed: June 6, 2024
    Publication date: August 21, 2025
    Inventor: David McCarthy
  • Patent number: 12390554
    Abstract: A heart valve replacement device and methods of manufacturing same are provided. The heart valve replacement device includes a substrate and a low-profile composite covering in conformal contact with the substrate and suturelessly attached to the substrate. The low-profile composite covering includes a textile base layer and a thermoplastic polymer coating integrated with the textile base layer. The thermoplastic polymer coating or select portions thereof are substantially fluid impermeable.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: August 19, 2025
    Assignee: Greatbatch Ltd.
    Inventors: David McCarthy, Tony Durkin, Dean King, Barry Nugent
  • Publication number: 20240148935
    Abstract: A heart valve replacement device and methods of manufacturing same are provided. The heart valve replacement device includes a substrate and a low-profile composite covering in conformal contact with the substrate and suturelessly attached to the substrate. The low-profile composite covering includes a textile base layer and a thermoplastic polymer coating integrated with the textile base layer. The thermoplastic polymer coating or select portions thereof are substantially fluid impermeable.
    Type: Application
    Filed: December 14, 2023
    Publication date: May 9, 2024
    Inventors: David McCarthy, Tony Durkin, Dean King, Barry Nugent
  • Publication number: 20230270917
    Abstract: A heart valve replacement device and methods of manufacturing same are provided. The heart valve replacement device includes a substrate and a low-profile composite covering in conformal contact with the substrate and suturelessly attached to the substrate. The low-profile composite covering includes a textile base layer and a thermoplastic polymer coating integrated with the textile base layer. The thermoplastic polymer coating or select portions thereof are substantially fluid impermeable.
    Type: Application
    Filed: May 2, 2023
    Publication date: August 31, 2023
    Inventors: David McCarthy, Tony Durkin, Dean King, Barry Nugent
  • Patent number: 11099199
    Abstract: Test devices to detect pregnancy in a human female subject are provided. In various embodiments, test devices include an assay means to measure the absolute or relative amount of hCG in a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and an assay means to measure the absolute or relative amount of one or more progesterone metabolites in a sample from the subject.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: August 24, 2021
    Assignee: SPD Swiss Precision Diagnostics GMBH
    Inventors: David McCarthy, Saji Eapen
  • Patent number: 10794920
    Abstract: Disclosed is a test device to detect pregnancy In a human female subject, the test device comprising: an assay means to measure the absolute or relative amount of hCG m a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and m assay means to measure the absolute or relative amount of one or mere progesterone metabolites I>> a sample from the subject.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: October 6, 2020
    Assignee: SPD Swiss Precision Diagnostics GmbH
    Inventors: Eapen Saji, David McCarthy
  • Publication number: 20190351099
    Abstract: A heart valve replacement and methods of manufacturing same are provided. A heart valve replacement includes a substrate and a low profile composite covering in conformal contact with the substrate and suturelessly attached to the substrate. The low profile composite covering includes a textile base layer and a thermoplastic polymer coating integrated with the textile base layer. The thermoplastic polymer coating or select portions thereof are substantially fluid impermeable.
    Type: Application
    Filed: May 21, 2019
    Publication date: November 21, 2019
    Inventors: David McCarthy, Tony Durkin, Dean King
  • Publication number: 20190204334
    Abstract: Test devices to detect pregnancy in a human female subject are provided. In various embodiments, test devices include an assay means to measure the absolute or relative amount of hCG in a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and an assay means to measure the absolute or relative amount of one or more progesterone metabolites in a sample from the subject.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Inventors: David McCarthy, Saji Eapen
  • Patent number: 10228377
    Abstract: Test devices to detect pregnancy in a human female subject are provided. In various embodiment, test devices include an assay means to measure the absolute or relative amount of hCG in a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and an assay means to measure the absolute or relative amount of one or more progesterone metabolites in a sample from the subject.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: March 12, 2019
    Assignee: SPD Swiss Precision Diagnostics GmbH
    Inventors: David McCarthy, Saji Eapen
  • Publication number: 20180088136
    Abstract: Disclosed is a test device to detect pregnancy In a human female subject, the test device comprising: an assay means to measure the absolute or relative amount of hCG m a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and m assay means to measure the absolute or relative amount of one or mere progesterone metabolites I>> a sample from the subject.
    Type: Application
    Filed: April 4, 2016
    Publication date: March 29, 2018
    Inventors: Eapen Saji, David Mccarthy
  • Publication number: 20170191069
    Abstract: The present invention provides methods to assemble and fuse a full length Abortive Promoter Cassette (APC) to a target nucleic acid during PCR amplification of the target. The linked APC is used to quantify amplicon abundance by the production of RNA Abscripts from the synthetic APC. Stepwise PCR-dependent promoter assembly allows for target-fusion of APCs that are too long to be synthesized as monolithic promoter-primer oligonucleotide reagents.
    Type: Application
    Filed: January 3, 2017
    Publication date: July 6, 2017
    Inventors: David McCarthy, Michelle M. Hanna
  • Publication number: 20150094227
    Abstract: Disclosed is a test device to detect pregnancy in a human female subject, the test device comprising: an assay means to measure the absolute or relative amount of hCG in a sample from the subject; an assay means to measure the absolute or relative amount of FSH in a sample from the subject; and an assay means to measure the absolute or relative amount of one or more progesterone metabolites in a sample from the subject.
    Type: Application
    Filed: October 2, 2014
    Publication date: April 2, 2015
    Inventors: David McCarthy, Saji Eapen
  • Publication number: 20140357369
    Abstract: Embodiments that relate to detecting via an image sensor inputs made by a group of users are provided. For example, one disclosed embodiment provides a method including receiving image information of the play space from a capture device, identifying a body of a user within the play space from the received image information, and identifying a head within the play space from the received image information. The method further includes associating the head with the body of the user, identifying an extremity, and if the extremity meets a predetermined condition relative to one or more of the head and body, then performing an action via the computing device.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 4, 2014
    Inventors: Adam Callens, Michael Scott Seamons, Roger Kurtz, Marie Elizabeth Whallon, Kim McAuliffe, Louise Mary Smith, Henry C. Sterchi, Soren Hannibal Nielsen, Michael Saxs Persson, David McCarthy, Bruce Heather, David Amor, Tim Aidley, Scott Rowlands
  • Publication number: 20130157266
    Abstract: The present invention provides methods for detecting biomarkers based on Abscription®, abortive transcription technology. Particularly, the present invention provides bisulfate free methods for detecting methylation of CpG islands from small samples containing DNA, including formalin fixed, paraffin embedded samples. The methods are suitable for multiplexing and can be used to analyze multiple CpG islands from a single sample in a short time.
    Type: Application
    Filed: September 10, 2012
    Publication date: June 20, 2013
    Applicant: RIBOMED BIOTECHNOLOGIES, INC.
    Inventors: Michelle M. Hanna, David McCarthy
  • Patent number: 8263339
    Abstract: The present invention provides methods for detecting biomarkers based on Abscription®, abortive transcription technology. Particularly, the present invention provides bisulfate free methods for detecting methylation of CpG islands from small samples of DNA. The methods are suitable for multiplexing and can be used to analyze multiple CpG islands from a single sample in a short time.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: September 11, 2012
    Assignee: RiboMed Biotechnologies, Inc.
    Inventors: Michelle M. Hanna, David McCarthy
  • Patent number: 8242243
    Abstract: The present invention provides a simple and sensitive technology for the detection of CpG methylation in DNA without chemical modification of sample DNA by bisulfite treatment or PCR amplification. Signal generation is based on an Abscription (Abortive Transcription) technology in which DNA signal generators called Abortive Promoter Cassettes (APCs) are bound to target mCpG sites via mCpG target specific probes based on methyl binding polypeptides or methyl binding domains thereof. RNA polymerase produces uniform, short RNA molecules from synthetic promoters in APCs as signals of the presence of methylated CpGs. Detection of CpG methylation and hypermethylation of DNA targets such as CpG islands provides a convenient means for detecting and monitoring cancer in a subject.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: August 14, 2012
    Assignee: RiboMed Biotechnologies, Inc.
    Inventors: Michelle M. Hanna, David McCarthy
  • Patent number: 8211644
    Abstract: The present invention provides methods for detecting targets using an Abscription assay that exploits molecular beacon-based detection technology. The methods of the invention are highly sensitive and can be performed on a NanoDrop scale and can be multiplexed for simultaneous detection of multiple targets.
    Type: Grant
    Filed: July 13, 2009
    Date of Patent: July 3, 2012
    Assignee: RiboMed Biotechnologies, Inc.
    Inventors: Michelle M. Hanna, David McCarthy
  • Patent number: 8152231
    Abstract: Collapsible seats may be installed on a track or rail system to allow the collapsible seats to move laterally within a vehicle's interior. The track system also may permit removal of the collapsible seats from the vehicle. The collapsible seats may include a seat back with multiple sections joined by flexible hinges that permit folding of the seat pan and seat back in a lateral direction. In certain embodiments, the seat pan or the headrest also may include multiple sections joined by flexible hinges. The flexible hinges may allow the seats to collapse laterally to reduce the width of the seats. The available space for seating or cargo storage may be adjusted by selectively collapsing, expanding, and removing the collapsible seats.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: April 10, 2012
    Assignee: Johnson Controls Technology Company
    Inventors: Lance Larsen, David McCarthy, Sheldon Watjer
  • Publication number: 20100233709
    Abstract: The present invention provides methods for detecting biomarkers based on Abscription®, abortive transcription technology. Particularly, the present invention provides bisulfate free methods for detecting methylation of CpG islands from small samples of DNA. The methods are suitable for multiplexing and can be used to analyze multiple CpG islands from a single sample in a short time.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 16, 2010
    Applicant: RIBOMED BIOTECHNOLOGIES, INC.
    Inventors: Michelle M. Hanna, David McCarthy
  • Publication number: 20100015622
    Abstract: The present invention provides methods for detecting targets using an Abscription assay that exploits molecular beacon-based detection technology. The methods of the invention are highly sensitive and can be performed on a NanoDrop scale and can be multiplexed for simultaneous detection of multiple targets.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 21, 2010
    Inventors: Michelle M. Hanna, David McCarthy